LivaNova PLC (LIVN) Stock

Healthcare · Medical Devices · Member of Other US Stocks

LivaNova PLC (LIVN) closed at USD 76.08 on 2026-10-14, a change of +41.3 % over the past year, with a market capitalization of USD 4.32B.

LivaNova PLC recent closing prices

DateClose (USD)
2026-10-1476.08
2026-10-1376.37
2026-10-1277.27
2026-10-0976.39
2026-10-0875.91
2026-10-0775.93
2026-10-0674.93

The most recent trading day is not shown. For full charts and indicators use the analysis page.

LivaNova PLC key figures

Previous close
USD 76.08 (2026-10-14)
1-year change
+41.3 %
Market cap
USD 4.32B
Enterprise value
USD 4.16B
P/E ratio (trailing)
22.62
P/E ratio (forward)
16.76
EPS (trailing)
3.47
EPS (forward)
4.68
PEG ratio
0.93
Price to book
3.26
Revenue growth
10.8 %
Earnings growth
287.8 %
Dividend per share (trailing)
0.00
Short ratio
9.07
Employees
3,300
Analyst consensus (third-party)
buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About LivaNova PLC

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for LivaNova PLC and compare it with other stocks.

Analyze LIVNAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell LivaNova PLC shares.